BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23237767)

  • 1. Paclitaxel, epirubicin, and cisplatin (TEP) regimen as neoadjuvant treatment in locally advanced cervical cancer: long-term results.
    Ferrandina G; Distefano MG; De Vincenzo R; Salutari V; Petrillo M; Scarciglia ML; Pietragalla A; Conte C; Scambia G
    Gynecol Oncol; 2013 Mar; 128(3):518-23. PubMed ID: 23237767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant treatment of locally advanced carcinoma of the uterine cervix with epirubicin, paclitaxel and cisplatin.
    D'Agostino G; Distefano M; Greggi S; Salerno M; Ferrandina G; Poerio A; Mancuso S; Scambia G
    Cancer Chemother Pharmacol; 2002 Mar; 49(3):256-60. PubMed ID: 11935219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The toxicity and long-term efficacy of nedaplatin and paclitaxel treatment as neoadjuvant chemotherapy for locally advanced cervical cancer.
    Yin M; Zhang H; Li H; Li X; Liu Y; Chen X; Lou G; Li K
    J Surg Oncol; 2012 Feb; 105(2):206-11. PubMed ID: 21815150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy with cisplatin and paclitaxel in locally advanced cervical cancer: has this regimen still a role as neoadjuvant setting?
    Moioli M; Papadia A; Mammoliti S; Pacella E; Menoni S; Menada MV; Ragni N
    Minerva Ginecol; 2012 Apr; 64(2):95-107. PubMed ID: 22481620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II multicentre study of efficacy and feasibility of dose-intensified preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) in resectable gastroesophageal cancer.
    Jary M; Ghiringhelli F; Jacquin M; Fein F; Nguyen T; Cleau D; Nerich V; El Gani M; Mathieu P; Valmary-Degano S; Arnould L; Lassabe C; Lamfichekh N; Fratté S; Paget-Bailly S; Bonnetain F; Borg C; Kim S
    Cancer Chemother Pharmacol; 2014 Jul; 74(1):141-50. PubMed ID: 24824852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant chemotherapy followed by radical surgery in patients affected by FIGO stage IVA cervical cancer.
    Benedetti Panici P; Bellati F; Manci N; Pernice M; Plotti F; Di Donato V; Calcagno M; Zullo MA; Muzii L; Angioli R
    Ann Surg Oncol; 2007 Sep; 14(9):2643-8. PubMed ID: 17562114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza.
    Zanetta G; Fei F; Mangioni C
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant docetaxel combined with cisplatin and followed by radical surgery for the treatment of locally advanced (stage IB2 - IIB) cervical cancer: preliminary results of a single-institution experience.
    Huang X; Lan C; Huang H; Zhang Y; Huang H; Cao X; Huang Y; Guo Y; Wan T; Liu J
    Expert Opin Pharmacother; 2011 Feb; 12(2):165-73. PubMed ID: 21226631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-Dense Neoadjuvant Chemotherapy plus Radical Surgery in Locally Advanced Cervical Cancer: A Phase II Study.
    Benedetti Panici P; Palaia I; Marchetti C; Ruscito I; Fischetti M; Musella A; Di Donato V; Perniola G; Vertechy L; Muzii L
    Oncology; 2015; 89(2):103-10. PubMed ID: 25924602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of paclitaxel/carboplatin in a dose dense or weekly regimen in 66 patients with recurrent or primary metastatic cervical cancer.
    Torfs S; Cadron I; Amant F; Leunen K; Berteloot P; Vergote I
    Eur J Cancer; 2012 Jun; 48(9):1332-40. PubMed ID: 22317951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II trial with cisplatin-paclitaxel cytotoxic treatment and concurrent external and endocavitary radiation therapy in locally advanced or recurrent cervical cancer.
    Miglietta L; Franzone P; Centurioni MG; Boni L; Tacchini L; Cosso M; Boccardo F; Ferrarini M; Bruzzone M
    Oncology; 2006; 70(1):19-24. PubMed ID: 16439862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer.
    Angioli R; Plotti F; Montera R; Aloisi A; Luvero D; Capriglione S; Terranova C; De Cicco Nardone C; Muzii L; Benedetti-Panici P
    Gynecol Oncol; 2012 Nov; 127(2):290-6. PubMed ID: 22819938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical outcomes of robotic radical hysterectomy after neoadjuvant chemotherapy for locally advanced cervical cancer: comparison with early stage disease.
    Vitobello D; Siesto G; Pirovano C; Ieda N
    Eur J Surg Oncol; 2013 Jan; 39(1):87-93. PubMed ID: 23122543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neoadjuvant chemotherapy with paclitaxel and cisplantin or carboplatin for patients with locally advanced uterine cervical cancer].
    Zhang R; Li B; Bai P; Li HJ; Li SM; Wu LY; Li W
    Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):616-20. PubMed ID: 22325224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial on neoadjuvant intravenous and trans-uterine arterial chemotherapy for locally advanced bulky cervical adenocarcinoma.
    Tsubamoto H; Maeda H; Kanazawa R; Ito Y; Ohama N; Hori M; Ikeda Y; Kato T; Sakane R; Hirota S
    Gynecol Oncol; 2013 Apr; 129(1):129-34. PubMed ID: 23333929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant chemotherapy and conservative surgery for stage IB1 cervical cancer.
    Maneo A; Chiari S; Bonazzi C; Mangioni C
    Gynecol Oncol; 2008 Dec; 111(3):438-43. PubMed ID: 18835493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
    Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
    Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical evaluation of effects from neoadjuvant chemotherapy with epirubicin plus paclitaxel in cases of locally advanced breast cancer--comparative study of treatment with 2 and 4 cycles].
    Tong F; Yang D; Zhou B; Cao Y; Liu P; Liu H; Wang S; Qiao X; Zhang J
    Gan To Kagaku Ryoho; 2004 Feb; 31(2):205-8. PubMed ID: 14997752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant cisplatin and etoposide followed by radical hysterectomy for stage 1B-2B cervical cancer.
    Bae JH; Lee SJ; Lee A; Park YG; Bae SN; Park JS; Namkoong SE
    Gynecol Oncol; 2008 Dec; 111(3):444-8. PubMed ID: 18829085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
    Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL
    Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.